Naperville, IL -- (SBWIRE) -- 10/08/2013 -- Reportstack, provider of premium market research reports announces the addition of Vertex Pharmaceuticals Incorporated - Product Pipeline Review - 2013 market report to its offering
Vertex Pharmaceuticals Incorporated - Product Pipeline Review - 2013
Global Market Directs pharmaceuticals report, Vertex Pharmaceuticals Incorporated - Product Pipeline Review - 2013 provides data on the Vertex Pharmaceuticals Incorporateds research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from proprietary databases, Vertex Pharmaceuticals Incorporateds corporate website, SEC filings, investor presentations and featured press releases, both from Vertex Pharmaceuticals Incorporated and industry-specific third party sources, put together by team.
- Vertex Pharmaceuticals Incorporated - Brief Vertex Pharmaceuticals Incorporated overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Vertex Pharmaceuticals Incorporated human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Vertex Pharmaceuticals Incorporated with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Vertex Pharmaceuticals Incorporateds pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Vertex Pharmaceuticals Incorporateds strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Vertex Pharmaceuticals Incorporated in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Vertex Pharmaceuticals Incorporateds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Vertex Pharmaceuticals Incorporated.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Vertex Pharmaceuticals Incorporated and identify potential opportunities in those areas.
To view the table of contents for this market research report please visit